11
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Bone Marrow Purging in Acute Leukemia with Alkyl-Lysophospholipids: A New Family of Anticancer Drugs

Pages 53-60 | Received 26 Jun 1993, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Faustino Mollinedo. (2007) Antitumour ether lipids: proapoptotic agents with multiple therapeutic indications. Expert Opinion on Therapeutic Patents 17:4, pages 385-405.
Read now

Articles from other publishers (11)

Shuraila F. Zerp, Stefan R. Vink, Gerald A. Ruiter, Pieter Koolwijk, Erna Peters, Arnold H. van der Luit, Daphne de Jong, Marianne Budde, Harry Bartelink, Wim J. van Blitterswijk & Marcel Verheij. (2008) Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents. Anti-Cancer Drugs 19:1, pages 65-75.
Crossref
O. Michael Colvin. 2003. Thomas' Hematopoietic Cell Transplantation. Thomas' Hematopoietic Cell Transplantation 254 257 .
Carolin Oberle, Ulrich Massing & Harald F. Krug. (2004) S‐1‐ O ‐phosphocholine‐2‐ N ‐acetyl‐octadecane induces apoptosis in T cells: Involvement of receptor activation and the intrinsic apoptotic pathway . Signal Transduction 3:5-6, pages 218-231.
Crossref
Gerald A. Ruiter, Shuraila F. Zerp, Harry Bartelink, Wim J. van Blitterswijk & Marcel Verheij. (2003) Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase–Akt/PKB survival pathway. Anti-Cancer Drugs 14:2, pages 167-173.
Crossref
Gregory S. Anderson, Ichiro Tsujino, Kiyoko Miyagi, Reynée Sampson & Fritz Sieber. (2003) Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic stem cell grafts. Journal of Photochemistry and Photobiology B: Biology 69:2, pages 87-95.
Crossref
Gerald A Ruiter, Marcel Verheij, Shuraila F Zerp & Wim J van Blitterswijk. (2001) Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis. International Journal of Radiation Oncology*Biology*Physics 49:2, pages 415-419.
Crossref
Klaudia Hettinger, Susanna Fischer, Simon Panzer & E. Renate Panzer‐GRÜmayer. (2001) Multiplex PCR for TCR delta rearrangements: a rapid and specific approach for the detection and identification of immature and mature rearrangements in ALL. British Journal of Haematology 102:4, pages 1050-1054.
Crossref
MARIA R.G. SILVA & JOAO L. ASCENSAO. (1995) In Vitro Effects of Etoposide Purging on Natural Killer Cells. Journal of Hematotherapy 4:6, pages 563-570.
Crossref
M. von Mehren, B. J. Giantonio, C. McAleer, R. Schilder, J. McPhillips & P. J. O'Dwyer. (1995) Phase I trial of ilmofosine as a 24 hour infusion weekly. Investigational New Drugs 13:3, pages 205-210.
Crossref
Kevin P. Boggs, Charles O. Rock & Suzanne Jackowski. (1995) Lysophosphatidylcholine and 1-O-Octadecyl-2-O-Methyl-rac- Glycero-3-Phosphocholine Inhibit the CDP-Choline Pathway of Phosphatidylcholine Synthesis at the CTP:Phosphocholine Cytidylyltransferase Step. Journal of Biological Chemistry 270:13, pages 7757-7764.
Crossref
Hans Brachwitz & Christine Vollgraf. (1995) Analogs of alkyllysophospholipids: Chemistry, effects on the molecular level and their consequences for normal and malignant cells. Pharmacology & Therapeutics 66:1, pages 39-82.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.